269 related articles for article (PubMed ID: 24942326)
1. Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.
Weidmann A; Foulkes AC; Kirkham N; Reynolds NJ
Dermatol Ther (Heidelb); 2014 Dec; 4(2):145-56. PubMed ID: 24942326
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate Cutaneous Toxicity following a Single Dose of 10 mg in a Case of Chronic Plaque Psoriasis: A Possible Idiosyncratic Reaction.
Gupta A; Sardana K; Bhardwaj M; Singh A
Indian Dermatol Online J; 2018; 9(5):328-330. PubMed ID: 30258802
[TBL] [Abstract][Full Text] [Related]
3. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
[TBL] [Abstract][Full Text] [Related]
4. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature.
Kurian A; Haber R
J Cutan Med Surg; 2011; 15(5):275-9. PubMed ID: 21962187
[TBL] [Abstract][Full Text] [Related]
6. Fatal low-dose methotrexate toxicity: A case report and literature review.
Ouellette S; Shah R; Razi S; Ashforth G; Wassef C
Dermatol Ther; 2022 Dec; 35(12):e15945. PubMed ID: 36259229
[TBL] [Abstract][Full Text] [Related]
7. Comparative tolerability of systemic treatments for plaque-type psoriasis.
McClure SL; Valentine J; Gordon KB
Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
[TBL] [Abstract][Full Text] [Related]
8. [4pp Mucocutaneous manifestations of methotrexate toxicity].
Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I
Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Berna R; Rosenbach M; Margolis DJ; Mitra N; Baumrin E
Am J Clin Dermatol; 2022 Jul; 23(4):449-457. PubMed ID: 35486323
[TBL] [Abstract][Full Text] [Related]
10. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate toxicity presenting as ulceration of psoriatic plaques: a report of two cases.
Agarwal KK; Nath AK; Thappa DM
Indian J Dermatol Venereol Leprol; 2008; 74(5):481-4. PubMed ID: 19052409
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous ulceration: an unusual sign of methotrexate toxicity--first report in a patient without psoriasis.
Ben-Amitai D; Hodak E; David M
Ann Pharmacother; 1998 Jun; 32(6):651-3. PubMed ID: 9640483
[TBL] [Abstract][Full Text] [Related]
13. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous ulceration as a sign of methotrexate toxicity.
Del Pozo J; Martínez W; García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
Eur J Dermatol; 2001; 11(5):450-2. PubMed ID: 11525955
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate toxicity in psoriasis-A multicentric retrospective study.
Singh GK; Sapra D; Bahuguna A; Das P
Dermatol Ther; 2022 Oct; 35(10):e15765. PubMed ID: 36054575
[TBL] [Abstract][Full Text] [Related]
16. Intralesional methotrexate in dermatology: Diverse indications and practical considerations.
Searle T; Ali FR; Al-Niaimi F
Dermatol Ther; 2021 Jan; 34(1):e14404. PubMed ID: 33044042
[TBL] [Abstract][Full Text] [Related]
17. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
Prey S; Paul C
Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
[TBL] [Abstract][Full Text] [Related]
18. Oral Squamous Cell Carcinoma Following Acute Methotrexate Toxicity in a Psoriasis Patient: A Causal Association or Mere Co-Incidence.
Choudhary R; Singh A; Chhabra N; Gupta AK
Curr Drug Saf; 2023; 18(4):580-583. PubMed ID: 36017826
[TBL] [Abstract][Full Text] [Related]
19. Folate supplementation during methotrexate therapy for patients with psoriasis.
Strober BE; Menon K
J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
[TBL] [Abstract][Full Text] [Related]
20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
